Table: Takara Bio -Q1 group results
Aug 8 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2023 Jun 30, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 9.18 14.10 53.30
(-34.9 pct) (-7.7 pct) (-31.8 pct)
Operating 423 mln 4.54 8.00
(-90.7 pct) (-46.6 pct) (-61.1 pct)
Recurring 509 mln 4.59 8.20
(-88.9 pct) (-46.5 pct) (-60.4 pct)
Net 319 mln 3.91 5.50
(-91.8 pct) (-35.1 pct) (-65.7 pct)
EPS 2.65 yen 32.45 yen 45.67 yen
Ann Div 42.00 yen 17.00 yen
-Q2 div NIL NIL
-Q4 div 42.00 yen 17.00 yen
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T